SIRS-Lab GmbH, a Jena, Germany-based developer of molecular diagnostics for life threatening infections, has raised Euro 10 million in venture funding. Affentranger Associates led the deal, and was joined by bm-t Beteiligungsmanagement Th
Nearly there!
We have just sent you an email so you can verify your account. Please check your spam or junk folder just in case
it’s been delivered there.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.